Trestolone acetate
Clinical data
Other namesOrgasteron acetate; MENT acetate; CDB-903; NSC-69948; U-15614; 7α-Methyl-19-nortestosterone 17β-acetate; 7α-Methylestr-4-en-17β-ol-3-one 17β-acetate
Routes of
administration		Intramuscular injection
Drug classAndrogen; Anabolic steroid; Androgen ester; Progestogen; Antigonadotropin
Identifiers
  • [(7R,8R,9S,10R,13S,14S,17S)-7,13-dimethyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H30O3
Molar mass330.468 g·mol−1
3D model (JSmol)
  • C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)OC(=O)C
  • InChI=1S/C21H30O3/c1-12-10-14-11-15(23)4-5-16(14)17-8-9-21(3)18(20(12)17)6-7-19(21)24-13(2)22/h11-12,16-20H,4-10H2,1-3H3/t12-,16+,17-,18+,19+,20-,21+/m1/s1
  • Key:IVCRCPJOLWECJU-XQVQQVTHSA-N

Trestolone acetate (USANTooltip United States Adopted Name; developmental code names CDB-903, NSC-69948, U-15614; also known as 7α-methyl-19-nortestosterone 17β-acetate (MENT acetate) and 7α-methylestr-4-en-17β-ol-3-one 17β-acetate) is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed.[1] It is an androgen ester – specifically, the C17 acetate ester of trestolone (7α-methyl-19-nortestosterone; MENT).[1] The medication was first described in 1963.[2]

See also

References

  1. ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 888–. ISBN 978-1-4757-2085-3.
  2. ^ Campbell JA, Lyster SC, Duncan GW, Babcock JC (1963). "7α-Methyl-18-norsteroids: A new class of potent anabolic and androgenic hormones". Steroids. 1 (3): 317–324. doi:10.1016/S0039-128X(63)80114-2.


Categories